Latest News and Press Releases
Want to stay updated on the latest news?
-
Filings submitted in Austria, Israel, and Serbia for a Phase 2 Clinical Trial with INM-755 creamAdditional submissions slated for France, Germany, Greece, and Italy over the next several days and...
-
VANCOUVER, British Columbia, April 27, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq:INM) (TSX:IN), a clinical-stage company developing cannabinoid-based...
-
VANCOUVER, British Columbia, April 26, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM; TSX:IN), a clinical-stage company developing cannabinoid-based...
-
VANCOUVER, British Columbia, March 03, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM; TSX:IN), a clinical-stage company developing cannabinoid-based...
-
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 12, 2018 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (TSX:IN)...
-
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, B.C., June 12, 2018 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (TSX:IN) (“InMed”...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 21, 2017) - NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES InMed...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 16, 2016) - InMed Pharmaceuticals Inc. ("InMed" or "the Company") (CSE:IN)(OTCQB:IMLFF), a biopharmaceutical company specializing...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 16, 2016) - InMed Pharmaceuticals Inc. ("InMed" or "the Company") (CSE:IN)(OTCQB:IMLFF), a biopharmaceutical company...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 23, 2015) - InMed Pharmaceuticals Inc. ("InMed") (CSE:IN)(OTCQB:IMLFF), a biopharmaceutical company specializing in the research and...